Abstract
BackgroundThe immunosuppressive microenvironment is closely related to tumorigenesis and cancer development, including colorectal cancer (CRC). The aim of the current study was to identify new immune biomarkers for the diagnosis and treatment of CRC.Materials and MethodsCRC data were downloaded from the Gene Expression Omnibus and The Cancer Genome Atlas databases. Sequences of immune-related genes (IRGs) were obtained from the ImmPort and InnateDB databases. Gene set enrichment analysis (GSEA) and transcription factor regulation analysis were used to explore potential mechanisms. An immune-related classifier for CRC prognosis was conducted using weighted gene co-expression network analysis (WGCNA), Cox regression analysis, and least absolute shrinkage and selection operator (LASSO) analysis. ESTIMATE and CIBERSORT algorithms were used to explore the tumor microenvironment and immune infiltration in the high-risk CRC group and the low-risk CRC group.ResultsBy analyzing the IRGs that were significantly associated with CRC in the module, a set of 13 genes (CXCL1, F2RL1, LTB4R, GPR44, ANGPTL5, BMP5, RETNLB, MC1R, PPARGC1A, PRKDC, CEBPB, SYP, and GAB1) related to the prognosis of CRC were identified. An IRG-based prognostic signature that can be used as an independent potentially prognostic indicator was generated. The ROC curve analysis showed acceptable discrimination with AUCs of 0.68, 0.68, and 0.74 at 1-, 3-, and 5- year follow-up respectively. The predictive performance was validated in the train set. The potential mechanisms and functions of prognostic IRGs were analyzed, i.e., NOD-like receptor signaling, and transforming growth factor beta (TGFβ) signaling. Besides, the stromal score and immune score were significantly different in high-risk group and low-risk group (p=4.6982e-07, p=0.0107). Besides, the proportions of resting memory CD4+ T cells was significantly higher in the high-risk groups.ConclusionsThe IRG-based classifier exhibited strong predictive capacity with regard to CRC. The survival difference between the high-risk and low-risk groups was associated with tumor microenvironment and immune infiltration of CRC. Innovative biomarkers for the prediction of CRC prognosis and response to immunological therapy were identified in the present study.
Highlights
Colorectal cancer (CRC) is one of the most common malignant tumors, and its morbidity and mortality are on the rise worldwide
By analyzing the immunerelated gene (IRG) that were significantly associated with CRC in the module, a set of 13 genes (CXCL1, F2R-like trypsin receptor 1 (F2RL1), leukotriene B4 receptor (LTB4R), GPR44, angiopoietin-like 5 (ANGPTL5), bone morphogenetic protein 5 (BMP5), resistin-like beta (RETNLB), melanocortin-1 receptor (MC1R), PPARGC1A, PRKDC, CCAAT enhancer binding protein beta (CEBPB), SYP, and GRB2-associatedbinding protein 1 (GAB1)) related to the prognosis of CRC were identified
DAVID analysis indicated that the IRGs were mainly enriched in the Biological process (BP) like delayed rectifier potassium (Figure 2B), were mainly associated with the cellular component post (CC) like synaptic membrane (Figure 2C), were mainly included in molecular function (MF) like lipoprotein particle binding (Figure 2D)
Summary
Colorectal cancer (CRC) is one of the most common malignant tumors, and its morbidity and mortality are on the rise worldwide. More than 1 million new cases of CRC are diagnosed globally every year [1], as are approximately 492,000 deaths [2]. Treatment techniques such as surgery, radiotherapy, and chemotherapy have been greatly improved, the prognosis remains poor. Numerous studies have subsequently revealed that tumor-infiltrating lymphocytes are closely related to the prognosis of CRC, and the degree of tumor regression after neoadjuvant radiotherapy in patients with locally advanced rectal cancer [7].
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
